Gilles H. Tapolsky
29Patents
9h-index
21Co-inventors
75Inventor score
Filing activity: Sep 9, 1993 → Dec 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5800832A | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces | Human Necessities | 169 | Expired |
| US6103266A | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues | Human Necessities | 153 | Expired |
| US7579019B2 | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | Human Necessities | 109 | Active |
| US6159498A | Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces | Human Necessities | 94 | Expired |
| US5955097A | Pharmaceutical preparation applicable to mucosal surfaces and body tissues | Human Necessities | 55 | Expired |
| US5811507A | Polyesterimides for use in linear and/or non-linear optics, and one method for preparing same | Chemistry; Metallurgy | 18 | Expired |
| US8557823B2 | Family of PFKFB3 inhibitors with anti-neoplastic activities | Human Necessities | 18 | Active |
| US6001958A | Crosslinkable polymer, particularly for optical and non-linear optical use, materials or devices using same, and method for preparing said polymer | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6290984A | Pharmaceutical preparation applicable to mucosal surfaces and body tissues | Human Necessities | 12 | Expired |
| US5324827A | Optionally oriented, monomeric and polymeric nonlinearly optically active materials and derivatives thereof | Physics | 3 | Expired |
| US8273789B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 2 | Active |
| US9403769B2 | Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics | Chemistry; Metallurgy | 2 | Active |
| US8552056B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 1 | Active |
| US10745408B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US11873308B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US10143677B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US11786504B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US11220512B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US11147793B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US9616043B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US9381172B2 | Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders | Chemistry; Metallurgy | 0 | Active |
| US10450323B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US10010542B2 | PFKFB3 inhibit and methods of use as an anti-cancer therapeutic | Chemistry; Metallurgy | 0 | Active |
| US9132118B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US5444136A | Optionally oriented, monomeric and polymeric nonlinearly optically active materials and derivatives thereof | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.